NM_000275.3:c.1365-15C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000275.3(OCA2):​c.1365-15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.631 in 1,612,918 control chromosomes in the GnomAD database, including 345,499 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.51 ( 23976 hom., cov: 32)
Exomes 𝑓: 0.64 ( 321523 hom. )

Consequence

OCA2
NM_000275.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.0380

Publications

21 publications found
Variant links:
Genes affected
OCA2 (HGNC:8101): (OCA2 melanosomal transmembrane protein) This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
OCA2 Gene-Disease associations (from GenCC):
  • oculocutaneous albinism type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 15-27983498-G-A is Benign according to our data. Variant chr15-27983498-G-A is described in ClinVar as Benign. ClinVar VariationId is 255720.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.706 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OCA2NM_000275.3 linkc.1365-15C>T intron_variant Intron 13 of 23 ENST00000354638.8 NP_000266.2 Q04671-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OCA2ENST00000354638.8 linkc.1365-15C>T intron_variant Intron 13 of 23 1 NM_000275.3 ENSP00000346659.3 Q04671-1
OCA2ENST00000353809.9 linkc.1293-15C>T intron_variant Intron 12 of 22 1 ENSP00000261276.8 Q04671-2

Frequencies

GnomAD3 genomes
AF:
0.506
AC:
76875
AN:
151970
Hom.:
23984
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.185
Gnomad AMI
AF:
0.738
Gnomad AMR
AF:
0.428
Gnomad ASJ
AF:
0.594
Gnomad EAS
AF:
0.147
Gnomad SAS
AF:
0.346
Gnomad FIN
AF:
0.743
Gnomad MID
AF:
0.636
Gnomad NFE
AF:
0.712
Gnomad OTH
AF:
0.511
GnomAD2 exomes
AF:
0.541
AC:
136088
AN:
251344
AF XY:
0.547
show subpopulations
Gnomad AFR exome
AF:
0.177
Gnomad AMR exome
AF:
0.371
Gnomad ASJ exome
AF:
0.593
Gnomad EAS exome
AF:
0.145
Gnomad FIN exome
AF:
0.742
Gnomad NFE exome
AF:
0.714
Gnomad OTH exome
AF:
0.594
GnomAD4 exome
AF:
0.644
AC:
941109
AN:
1460830
Hom.:
321523
Cov.:
41
AF XY:
0.638
AC XY:
463606
AN XY:
726796
show subpopulations
African (AFR)
AF:
0.167
AC:
5586
AN:
33458
American (AMR)
AF:
0.381
AC:
17028
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.596
AC:
15564
AN:
26128
East Asian (EAS)
AF:
0.116
AC:
4612
AN:
39698
South Asian (SAS)
AF:
0.365
AC:
31495
AN:
86230
European-Finnish (FIN)
AF:
0.743
AC:
39650
AN:
53398
Middle Eastern (MID)
AF:
0.583
AC:
3362
AN:
5764
European-Non Finnish (NFE)
AF:
0.709
AC:
787827
AN:
1111066
Other (OTH)
AF:
0.596
AC:
35985
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
15692
31384
47076
62768
78460
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19190
38380
57570
76760
95950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.505
AC:
76857
AN:
152088
Hom.:
23976
Cov.:
32
AF XY:
0.500
AC XY:
37181
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.185
AC:
7659
AN:
41470
American (AMR)
AF:
0.428
AC:
6532
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.594
AC:
2063
AN:
3472
East Asian (EAS)
AF:
0.147
AC:
759
AN:
5166
South Asian (SAS)
AF:
0.346
AC:
1665
AN:
4812
European-Finnish (FIN)
AF:
0.743
AC:
7870
AN:
10592
Middle Eastern (MID)
AF:
0.639
AC:
188
AN:
294
European-Non Finnish (NFE)
AF:
0.712
AC:
48374
AN:
67978
Other (OTH)
AF:
0.508
AC:
1074
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1509
3018
4526
6035
7544
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
644
1288
1932
2576
3220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.629
Hom.:
19827
Bravo
AF:
0.472
Asia WGS
AF:
0.296
AC:
1030
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jun 20, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 09, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tyrosinase-positive oculocutaneous albinism Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.0
DANN
Benign
0.50
PhyloP100
0.038
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12910433; hg19: chr15-28228644; COSMIC: COSV62344987; API